Editorial Commentary: Galactomannan Testing During Mold-Active Prophylaxis

Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)

(2011) M. Ruhnke et al.   ANNALS OF ONCOLOGY

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

(2011) M. R. Ananda-Rajah et al.   HAEMATOLOGICA

Bronchoalveolar Lavage Fluid Galactomannan for Diagnosis of Invasive Pulmonary Aspergillosis

(2010) Bart J. A. Rijnders et al.   CLINICAL INFECTIOUS DISEASES

Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort

(2010) J. J. Vehreschild et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases

(2009) Johan Maertens et al.   CLINICAL INFECTIOUS DISEASES

Posaconazole-increased Vincristine Neurotoxicity in a Child

(2009) Céline Eiden et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY